<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Tissue Barriers</journal-id>
<journal-id journal-id-type="iso-abbrev">Tissue Barriers</journal-id>
<journal-id journal-id-type="publisher-id">KTIB</journal-id>
<journal-id journal-id-type="publisher-id">ktib20</journal-id>
<journal-title-group>
<journal-title>Tissue Barriers</journal-title>
</journal-title-group>
<issn pub-type="ppub">2168-8362</issn>
<issn pub-type="epub">2168-8370</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29420166</article-id>
<article-id pub-id-type="pmc">5823546</article-id>
<article-id pub-id-type="publisher-id">1425085</article-id>
<article-id pub-id-type="doi">10.1080/21688370.2018.1425085</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects</article-title>
<alt-title alt-title-type="running-authors">S. S. GHOSH ET AL.</alt-title>
<alt-title alt-title-type="running-title">TISSUE BARRIERS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ghosh</surname>
<given-names>Siddhartha S.</given-names>
</name>
<xref ref-type="aff" rid="af0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Hongliang</given-names>
</name>
<xref ref-type="aff" rid="af0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="af0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gehr</surname>
<given-names>Todd W.</given-names>
</name>
<xref ref-type="aff" rid="af0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghosh</surname>
<given-names>Shobha</given-names>
</name>
<xref ref-type="aff" rid="af0001"></xref>
<xref ref-type="corresp" rid="an0001"></xref>
</contrib>
<aff id="af0001"><institution>Department of Internal Medicine, Virginia Commonwealth University Medical Center</institution>, Richmond, VA </aff>
</contrib-group>
<author-notes>
<corresp id="an0001"><bold>CONTACT</bold> Shobha Ghosh, PhD, FAHA <email xlink:href="shobha@vcu.edu">shobha@vcu.edu</email><institution>Department of Internal Medicine</institution>, <addr-line>MMRB 6050, 1220 E Broad Street</addr-line>, Richmond, VA 23298-0050</corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>8</day>
<month>2</month>
<year>2018</year>
</pub-date>
<volume>6</volume>
<issue>1</issue>
<elocation-id seq="6">e1425085</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 Taylor &amp; Francis</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Taylor &amp; Francis</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="ktib-06-01-1425085.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Curcumin has anti-inflammatory, anti-oxidant and anti-proliferative properties established largely by in vitro studies. Accordingly, oral administration of curcumin beneficially modulates many diseases including diabetes, fatty-liver disease, atherosclerosis, arthritis, cancer and neurological disorders such as depression, Alzheimer's or Parkinson's disease. However, limited bioavailability and inability to detect curcumin in circulation or target tissues has hindered the validation of a causal role. We established curcumin-mediated decrease in the release of gut bacteria-derived lipopolysaccharide (LPS) into circulation by maintaining the integrity of the intestinal barrier function as the mechanism underlying the attenuation of metabolic diseases (diabetes, atherosclerosis, kidney disease) by curcumin supplementation precluding the need for curcumin absorption. In view of the causative role of circulating LPS and resulting chronic inflammation in the development of diseases listed above, this review summarizes the mechanism by which curcumin affects the several layers of the intestinal barrier and, despite negligible absorption, can beneficially modulate these diseases.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>KEYWORDS</title>
<kwd>Chronic inflammation</kwd>
<kwd>Curcumin</kwd>
<kwd>Endotoxemia</kwd>
<kwd>Intestinal Barrier</kwd>
<kwd>Lipopolysaccharide</kwd>
<kwd>Para-cellular Transport</kwd>
<kwd>Tight Junctions</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<named-content content-type="funder-name">American Diabetes Association (ADA)</named-content>
</funding-source>
<award-id>1-16-IBS-105</award-id>
</award-group>
<funding-statement>This work was supported by the American Diabetes Association (ADA) (1-16-IBS-105).</funding-statement>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="107"></ref-count>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>